Please check your internet connection and try again.
# Lorazepam (Benzodiazepine)
## Overview
Lorazepam is a short-acting benzodiazepine with anxiolytic, sedative, hypnotic, anticonvulsant, and muscle relaxant properties. It is metabolized by glucuronidation, leading to a lower risk of drug-drug interactions compared to other benzodiazepines metabolized by the cytochrome P450 system.
## Primary Indications
* Anxiety disorders
* Insomnia due to anxiety
* Seizure management (status epilepticus, acute repetitive seizures)
* Preoperative sedation and anxiolysis
* Management of alcohol withdrawal symptoms
## Adult Dosing
* **Anxiety:** 1-4 mg orally every 6-8 hours as needed.
* **Insomnia:** 2-4 mg orally at bedtime.
* **Status Epilepticus:** 4 mg intravenously (IV) or intramuscularly (IM). A repeat dose of 4 mg may be given after 5-10 minutes if seizures persist. **Maximum initial dose is 4 mg.**
* **Preoperative Sedation:** 2-4 mg IM 2 hours before surgery.
* **Alcohol Withdrawal:** 1-4 mg orally or IV/IM every 4-6 hours as needed. Dosing should be guided by symptom severity.
## Pediatric Dosing
* **Anxiety/Sedation:** Dosing is highly variable and should be individualized based on age, weight, and clinical condition. Common oral doses range from 0.02-0.05 mg/kg/dose every 6-8 hours.
* **Status Epilepticus:** 0.1 mg/kg IV/IM (maximum 4 mg/dose) given slowly over 2-5 minutes. May repeat once after 5-10 minutes if seizures persist.
* **Preoperative Sedation:** 0.05 mg/kg IM (maximum 4 mg) 2 hours before surgery.
Dosing for pediatric patients, especially for status epilepticus and preoperative sedation, requires careful consideration and adherence to institutional protocols.
## Dose Adjustments
* **Hepatic Impairment:** Use with caution. No specific dose adjustment is recommended by the manufacturer, but reduced doses may be necessary due to impaired metabolism.
* **Renal Impairment:** No specific dose adjustment is recommended by the manufacturer.
## Contraindications
* Hypersensitivity to lorazepam or other benzodiazepines.
* Acute narrow-angle glaucoma.
* Severe respiratory insufficiency.
* Severe hepatic insufficiency.
* Myasthenia gravis (caution advised).
* Sleep apnea.
## Adverse Effects
* **Common:** Drowsiness, dizziness, weakness, unsteadiness, sedation.
* **Less Common:** Confusion, depression, amnesia, ataxia, blurred vision, hypotension, respiratory depression (especially with IV administration or in combination with other CNS depressants).
* **Rare:** Paradoxical reactions (agitation, excitement), extrapyramidal symptoms, slurred speech.
## Key Drug Interactions
* **CNS Depressants (e.g., opioids, alcohol, sedating antihistamines, other benzodiazepines, antipsychotics):** Additive CNS depression, leading to profound sedation, respiratory depression, coma, and death. **Use with extreme caution and consider dose reduction of one or both agents.**
* **Theophylline and Aminophylline:** May antagonize the sedative effects of lorazepam.
## Monitoring
* Level of consciousness and sedation.
* Respiratory rate and depth.
* Blood pressure.
* Signs of withdrawal upon discontinuation.
* For IV administration: injection site for extravasation.
## Clinical Pearls
* Lorazepam is available in oral, sublingual, intramuscular, and intravenous formulations. The IV formulation can be used for status epilepticus, but it may precipitate if mixed with certain solutions.
* Intramuscular lorazepam is generally well-absorbed.
* Sublingual lorazepam offers faster onset than oral administration.
* Abrupt discontinuation can lead to withdrawal symptoms, including insomnia, anxiety, tremors, and seizures. Tapering of the dose is recommended.
* Use in elderly patients: Start with lower doses and titrate slowly due to increased sensitivity to CNS effects and risk of falls.
***
**Disclaimer:** This information is intended for healthcare professionals. Always consult the most current prescribing information and institutional protocols before administering any medication.
